Sandoz to Pay Around $480 Million to Settle U.S. Antitrust Pricing Litigations

Date:




The agreements mean the remaining claims against the Swiss maker of generic drugs in the U.S. generic antitrust litigation are those from individual plaintiffs.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related